128 related articles for article (PubMed ID: 10217344)
1. Predictive capacity of carbamazepine pharmacokinetic parameters in a Portuguese outpatient population.
Falcão AC; de Almeida AM; Leitão F; Santos J; Sales F; Caramona MM
Ther Drug Monit; 1999 Apr; 21(2):224-30. PubMed ID: 10217344
[TBL] [Abstract][Full Text] [Related]
2. Bayesian estimation of six different sets of carbamazepine pharmacokinetic parameters in Egyptian adult epileptic patients.
EL Desoky ES; Kandil MR
Pharmacol Res; 2002 Feb; 45(2):113-8. PubMed ID: 11846622
[TBL] [Abstract][Full Text] [Related]
3. Predictions of carbamazepine concentrations using a Bayesian program (PKS System, Abbott): a retrospective evaluation in an outpatient population.
Gaulier JM; Boulieu R; Fischer C; Mauguiere F
J Pharm Pharmacol; 1997 Jul; 49(7):734-6. PubMed ID: 9255721
[TBL] [Abstract][Full Text] [Related]
4. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
Carlsson KC; Hoem NO; Glauser T; Vinks AA
Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
[TBL] [Abstract][Full Text] [Related]
5. Kinetic profile of carbamazepine in an adult Portuguese outpatient population.
Almeida AM; Falcão AC; Sales F; Leitão F; Santos J; Costa IM; Caramona MM
J Clin Pharm Ther; 1998 Aug; 23(4):315-21. PubMed ID: 9867316
[TBL] [Abstract][Full Text] [Related]
6. Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy.
Bondareva IB; Jelliffe RW; Andreeva OV; Bondareva KI
J Clin Pharm Ther; 2011 Oct; 36(5):625-36. PubMed ID: 21062333
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic modelling of carbamazepine by using the iterative Bayesian (IT2B) and the nonparametric EM (NPEM) algorithms: implications for dosage.
Bondareva IB; Sokolov AV; Tischenkova IF; Jelliffe RW
J Clin Pharm Ther; 2001 Jun; 26(3):213-23. PubMed ID: 11422606
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of free carbamazepine in adult Omani epileptic patients.
Deleu D; Aarons L; Ahmed IA
Eur J Clin Pharmacol; 2001 Jun; 57(3):243-8. PubMed ID: 11497340
[TBL] [Abstract][Full Text] [Related]
9. Comparison of equations for predicting bound serum concentrations of carbamazepine and carbamazepine-10, 11-epoxide after polytherapy in patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Tsutsumi K; Fujii I; Takeyama M
J Clin Pharmacol; 1995 Oct; 35(10):995-1002. PubMed ID: 8568018
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage.
Bondareva IB; Jelliffe RW; Gusev EI; Guekht AB; Melikyan EG; Belousov YB
J Clin Pharm Ther; 2006 Jun; 31(3):211-21. PubMed ID: 16789986
[TBL] [Abstract][Full Text] [Related]
12. Comparison between the Cobas Integra immunoassay and high-performance liquid chromatography for therapeutic monitoring of carbamazepine.
Hermida J; Bóveda MD; Vadillo FJ; Tutor JC
Clin Biochem; 2002 May; 35(3):251-4. PubMed ID: 12074835
[TBL] [Abstract][Full Text] [Related]
13. Performance of gentamicin population kinetic parameters in Portuguese neonates.
Rocha MJ; Almeida AM; Falcão AC; Caramona MM
Pharm World Sci; 2007 Jun; 29(3):104-8. PubMed ID: 17353969
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of carbamazepine in adults with epilepsy.
Graves NM; Brundage RC; Wen Y; Cascino G; So E; Ahman P; Rarick J; Krause S; Leppik IE
Pharmacotherapy; 1998; 18(2):273-81. PubMed ID: 9545146
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of carbamazepine in Singapore epileptic patients.
Chan E; Lee HS; Hue SS
Br J Clin Pharmacol; 2001 Jun; 51(6):567-76. PubMed ID: 11422016
[TBL] [Abstract][Full Text] [Related]
16. Comparison of methods of carbamazepine dosage, individualization in epileptic patients.
Garcia MJ; Alonso AC; Maza A; Santos D; Matesanz C; Dominguez-Gil A
J Clin Pharm Ther; 1988 Dec; 13(6):375-80. PubMed ID: 3235481
[TBL] [Abstract][Full Text] [Related]
17. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data.
Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
Epilepsia; 2003 Jul; 44(7):923-9. PubMed ID: 12823575
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution rates.
Aldenkamp AP; Rentmeester T; Hulsman J; Majoie M; Doelman J; Diepman L; Schellekens A; Franken M; Olling M
Eur J Clin Pharmacol; 1998 Apr; 54(2):185-92. PubMed ID: 9626926
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of unbound serum carbamazepine and carbamazepine-10,11-epoxide concentration prediction methods in polytherapy adult patients with epilepsy.
Kodama Y; Kuranari M; Fujii I; Kodama H; Takeyama M
Am J Ther; 1996 Oct; 3(10):699-707. PubMed ID: 11862225
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a bayesian pharmacokinetic program for phenytoin concentration predictions in outpatient population.
Gaulier JM; Boulieu R; Fischer C; Mauguiere
Eur J Drug Metab Pharmacokinet; 1998; 23(2):295-300. PubMed ID: 9725496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
